SCHEMBL7781097

SCHEMBL7781097

N=C(N)NN(c1cccc(C(CC(=O)O)NC(=O)C23CC4CC(CC(C4)C2)C3)c1)S(=O)(=O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
LMNA P02545 2/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
POLB P06746 1/20 0.42
ALDH1A1 P00352 4/20 0.35
ALOX12 P18054 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPT P10636 1/20 0.35
ENPP3 O14638 1/20 0.35
CA2 P00918 1/20 0.35
ENPP1 P22413 1/20 0.35
ENPP2 Q13822 1/20 0.35
CA9 Q16790 1/20 0.35
HSD11B1 P28845 2/20 0.35
HPGD P15428 2/20 0.34
USP2 O75604 1/20 0.34
ITGB3 P05106 1/20 0.34
ITGA2B P08514 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7788304 0.83 ITGB3 (0.42) SMN1; SMN2POLBITGB3ITGA2B
SCHEMBL7194899 0.82 ITGB3 (0.44) KMT2AMEN1LMNASMN1; SMN2ALDH1A1
SCHEMBL7790182 0.82 SMN1; SMN2 (0.42) LMNASMN1; SMN2POLBITGB3ITGA2B
SCHEMBL7788171 0.81 SMN1; SMN2 (0.43) LMNASMN1; SMN2MAPTITGB3ITGA2B
SCHEMBL7788768 0.79 ATM (0.40) LMNASMN1; SMN2POLBALDH1A1MAPT
SCHEMBL7785595 0.79 MMP12 (0.42) KMT2AMEN1SMN1; SMN2ALDH1A1ALOX12
SCHEMBL7781206 0.79 ITGB3 (0.42) KMT2AMEN1ALOX12MAPTCA9
SCHEMBL7191718 0.79 ALDH1A1 (0.36) KMT2AMEN1SMN1; SMN2POLBALDH1A1
SCHEMBL7789969 0.78 CYP26A1 (0.42) LMNASMN1; SMN2ALDH1A1MAPTITGB3
SCHEMBL7790178 0.78 CTSA (0.41) KMT2AMEN1MAPTITGB3ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147079-A2 BETA-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS Bayer Aktiengesellschaft (DE) 2001-10-24 EP disclosed
WO-2000041469-A2 β-PHENYLALANINE DERIVATIVES AS INTEGRIN ANTAGONISTS BAYER AKTIENGESELLSCHAFT (DE) 2000-07-20 WO disclosed